SULCIN

Main information

  • Trade name:
  • VR SULCIN BACTERIAL ENTERITIS TREATMENT
  • Available from:
  • VR
  • Pharmaceutical form:
  • ORAL POWDER, PRE-MIX
  • Units in package:
  • 500g
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • JUROX

Documents

Localization

  • Available in:
  • VR SULCIN BACTERIAL ENTERITIS TREATMENT
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CALF | BEEF CALF | BOVINE | CALF - PODDY | CALF - PREWEANING | CALF - SUCKER | DAIRY CALF | NEONATAL CALF
  • Therapeutic area:
  • antibiotic
  • Therapeutic indications:
  • DIARRHOEA | ABSORPTIVE | ACUTE DIARRHOEA | ACUTE INTESTINAL CATARRH | AVIAN BLACKHEAD | BACTERIAL ENTERITIS | BLACKHEAD | CHRONIC DIARRHOEA | COCCIDIOSIS | DIETARY FACTORS | DIETARY UPSET | ENTERITIS | FEED CONVERSION | FLATULANCE | FLUID LOSS | GASTRO-INTESTINAL | GRAM NEGATIVE BACTERIA | GROWTH RATE | K88+ SEROTYPES OF E.COLI | NESTING DIARRHOEA | NON-SPECIFIC IRRITANTS | POISONING | POSTWEANING SCOURS | PROPHYLACTIC | SCOURS | STREPTOMYCIN SENSITIVE BACTERI | SULPHADIAZINE SENSITIVE BACTER | SULPHONAMIDE SENSITIVE BACTERI | TRICHOMONIASIS | TRIMETHOPRIM SENSITIVE BACTERI | WHITE SCOURS
  • Product summary:
  • For the treatment of calf scours.Ensure adequate fresh water is available to animals undergoing treatment.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 36265/0101
  • Authorization date:
  • 11-01-2001
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

VR SULCIN BACTERIAL ENTERITIS TREATMENT

Labelling

12/12/00

page 1/1

Jurox Pty Ltd

Main panel

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

VR SULCIN

BACTERIAL ENTERITIS TREATMENT

Active Constituents:

375 mg/g SULFADIMIDINE

375 mg/g SULFADIAZINE

40 mg/g STREPTOMYCIN (as the SULFATE)

1 mg/g THIAMINE HYDROCHLORIDE

1 mg/g RIBOFLAVINE

For the treatment of calf scours

500 g NET

JUROX

Panel 2

DIRECTIONS FOR USE:

Ensure adequate fresh water is available to animals undergoing treatment.

Give 2g (one full measuring spoon) per 10kg liveweight daily.

The granules may be mixed with the food or given as a drench. Repeat treatment daily until 2

days after symptoms have subsided except in cases of salmonellosis where treatment should

continue for a minimum of 5 consecutive days.

WITHHOLDING PERIOD:

DO NOT USE less than 14 days before slaughter for human consumption.

Panel 3

Made in Australia by

Jurox Pty Ltd, 85 Gardiners Rd, Rutherford NSW 2320.

Infoline 1800 023 312

DISPOSE of container by wrapping in paper and putting in garbage.

STORE below 30

C (Room Temperature).

xxxxx NRA36265/0101

EXP.

31-7-2018

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection 3.375 grams per vial, Due to Presence of Particulates Identified as Glass and Silicone Material

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection 3.375 grams per vial, Due to Presence of Particulates Identified as Glass and Silicone Material

East Windsor, New Jersey, AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level. One vial from lot# PP0317012-A was found to contain particulate matter, identified as glass within the vial and another vial from lot# PP0317059-A was fo...

FDA - U.S. Food and Drug Administration

8-5-2018

Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

Piperacillin and Tazobactam for Injection, USP 3.375 g by AuroMedics Pharma: Recall: Exposure to particulate matter may result in local irritation/swelling or more serious outcomes.

FDA - U.S. Food and Drug Administration

16-5-2018

EU/3/06/375 (Novartis Europharm Limited)

EU/3/06/375 (Novartis Europharm Limited)

EU/3/06/375 (Active substance: Nilotinib) - Transfer of orphan designation - Commission Decision (2018)3033 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/003/06/T/01

Europe -DG Health and Food Safety